The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

dc.contributor.authorYildiz, Ramazan
dc.contributor.authorBuyukberber, Suleyman
dc.contributor.authorKoca, Dogan
dc.contributor.authorKorai, Lokman
dc.contributor.authorCiltas, Aydin
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorGumus, Mahmut
dc.date.accessioned2020-03-26T18:44:00Z
dc.date.available2020-03-26T18:44:00Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, ILen_US
dc.description.abstract[Abstract not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issn1527-7755en_US
dc.identifier.issue15en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/29924
dc.identifier.volume31en_US
dc.identifier.wosWOS:000335419603655en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAMER SOC CLINICAL ONCOLOGYen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleThe efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.en_US
dc.typeConference Objecten_US

Dosyalar